English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Mar 17, 2024

Professor of audiology: 'We don’t want the auditory system deprived of sound'

+ Pharmaceuticals
Patient Daily | Mar 9, 2024

Researcher of Hamamatsu Photonics: 'This phase delay-based metabolic index is a scientifically important discovery'

+ Pharmaceuticals
Patient Daily | Mar 9, 2024

Former FDA Commissioner: 'Wegovy is going to have the better label'

+ Pharmaceuticals
Patient Daily | Mar 8, 2024

Doctor at Baylor College of Medicine: 'All seasons can bring different allergens'

+ Pharmaceuticals
Patient Daily | Mar 8, 2024

Doctor of Mayo Clinic: 'Prevention of peripheral artery disease is always the best treatment'

+ Pharmaceuticals
Patient Daily News Service | Mar 8, 2024

STAT News Reporter: If Biden’s proposed drug price negotiation expansion makes drugs ‘less profitable there will probably be fewer drugs’

+ Pharmaceuticals
Patient Daily | Mar 7, 2024

Sharp Medical Group endocrinologist: 'Thyroid issues may be more common after childbirth and menopause'

+ Pharmaceuticals
Patient Daily | Feb 28, 2024

Michel Barsoum: 'A murmur could indicate a serious heart problem'

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'

+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes

  • « First
  • «
  • …
  • 271
  • 272
  • 273
  • 274
  • 275
  • 276
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily